ADGRG1 and acute myeloid leukemia: We applied ATAC‐seq to 35 primary human AML samples, which represented the full range from low to very high protein expression levels of the LSC marker GPR56, to identify leukemia‐driving pathways in GPR56high AML (Fig 1A, Dataset EV1).